Lilly gears up for 'top-tier' growth to 2025 thanks to its new launches

30th January 2020 Uncategorised 0

Eli Lilly has a posse of newer meds bringing in a big chunk of the company’s sales—including blockbuster Trulicity and Taltz—and that group could grow by three members just this year, executives said Thursday. All that action is expected to drive the company to “top-tier” growth through 2025.

More: Lilly gears up for 'top-tier' growth to 2025 thanks to its new launches
Source: fierce